EPANOVA in Crohn's Disease, Study 1

Clinical trial NCT00613197 · COMPLETED

Trial details

NCT number: NCT00613197
Sponsor: Tillotts Pharma AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2003-01-01
Primary completion: 2006-08-01
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.